AxoGen, Inc. (AXGN) Financials

AXGN Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 304.9 million 48.6 million
March 31, 2026 289.5 million 44.7 million
Dec. 31, 2025 221.7 million 92.8 million
Sept. 30, 2025 216.4 million 95.6 million

AXGN Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 601000 8.8 million
March 31, 2026 -1.2 million 6.8 million
Dec. 31, 2025 1.8 million 16.6 million
Sept. 30, 2025 1.4 million 5.4 million

AXGN Net Income

No data available :(

AXGN Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 94.6 million 18.1 million 20.1 million
March 31, 2026 82.7 million 18.5 million 2.1 million
Dec. 31, 2025 35.5 million 48.4 million 19.2 million
Sept. 30, 2025 35.8 million 48.2 million 19.8 million

AXGN Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 53.3 million
March 31, 2026 51.6 million
Dec. 31, 2025 46.9 million
Sept. 30, 2025 45.9 million

AXGN Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 893000 8.6 million 44.2 million 30.8 million
March 31, 2026 2.8 million 7.5 million 41.5 million 28.6 million
Dec. 31, 2025 1.2 million 12.4 million 41.8 million 27.2 million
Sept. 30, 2025 1.9 million 7.6 million 36.5 million 25.7 million

AXGN Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 69.7 million 19.1 million
March 31, 2026 61.5 million 15.3 million
Dec. 31, 2025 59.9 million 15.5 million
Sept. 30, 2025 60.1 million 14.1 million

AXGN

Price: $48.73

52 week price:
13.50
49.67

Dividend Yield: 2.25%

Payout Ratio Range:
-1747.81%
59.60%

Earnings Per Share: -0.68 USD

Exchange: NCM

Sector: Healthcare

Industry: Medical Devices

Country: United States

Volume: 233500

Ebitda: -1.4 million

Market Capitalization: 2.4 billion

Links: